Watch Ticker

ATAI Life Sciences N.V. Common Shares

Go to ATAI Life Sciences N.V. Common Shares Website

$4.16

-0.01 (-0.24%)

Live

Previous Close

$4.17

Day Range

$4.01 - $4.4

Previous Day Range

$3.82 - $4.275

Market Cap

$884.6 million USD

Day Vol.

3.6 million

Previous Day Vol.

7.7 million

Currency

USD

Primary Exchange

Nasdaq

ATAI Life Sciences NV is a clinical-stage biopharmaceutical company on a mission to develop effective mental health treatments to transform patient outcomes. The company's pipeline of psychedelic-based therapies includes VLS-01 (buccal film DMT) for ...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Atai Life Sciences And Beckley Psytech - atai Life Sciences and Beckley Psytech Announce Positive Topline Results from the Phase 2b Study of BPL-003 in Patients with Treatment-Resistant Depression

atai Life Sciences and Beckley Psytech reported successful Phase 2b clinical trial results for BPL-003, a potential treatment for treatment-resistant depression, demonstrating rapid and durable antidepressant effects with a single intranasal dose and minimal side effects.

Related tickers: ATAI.

Read Full Article

N/A - SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates LNSR, ATAI, ICAD on Behalf of Shareholders

Halper Sadeh LLC, an investor rights law firm, is investigating LENSAR, Atai Life Sciences, and iCAD for potential violations of federal securities laws and/or breaches of fiduciary duties to shareholders related to proposed mergers and acquisitions.

Related tickers: LNSR, ATAI, ICAD.

Read Full Article

Trending Tickers

Please sign in to view